{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:19:48Z","timestamp":1790777988937,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T00:00:00Z","timestamp":1568592000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T00:00:00Z","timestamp":1568592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["R21 EB026675"],"award-info":[{"award-number":["R21 EB026675"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"publisher","award":["Scholar Award"],"award-info":[{"award-number":["Scholar Award"]}],"id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["NCI P30 CA047904"],"award-info":[{"award-number":["NCI P30 CA047904"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11307-019-01427-1","type":"journal-article","created":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T13:02:47Z","timestamp":1568638967000},"page":"685-694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Preclinical ImmunoPET Imaging of Glioblastoma-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody"],"prefix":"10.1007","volume":"22","author":[{"given":"Shubhanchi","family":"Nigam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"McCarl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Edinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda F.","family":"Kurland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Panigrahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3953-8022","authenticated-orcid":false,"given":"Gary","family":"Kohanbash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Barry","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,16]]},"reference":[{"key":"1427_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/nox158","volume":"19","author":"QT Ostrom","year":"2017","unstructured":"Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS (2017) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro-Oncology 19:v1\u2013v88","journal-title":"Neuro-Oncology"},{"key":"1427_CR2","first-page":"796","volume":"19","author":"JP Antonios","year":"2017","unstructured":"Antonios JP, Soto H, Everson RG et al (2017) Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1\/PD-L1 mechanism in glioblastoma. Neuro-Oncology 19:796\u2013807","journal-title":"Neuro-Oncology"},{"key":"1427_CR3","doi-asserted-by":"publisher","unstructured":"Gabrusiewicz K, Rodriguez B, Wei J et al (2016) Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype. JCI insight 1. https:\/\/doi.org\/10.1172\/jci.insight.85841","DOI":"10.1172\/jci.insight.85841"},{"key":"1427_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/486912","volume":"2013","author":"Benjamin C. Kennedy","year":"2013","unstructured":"Kennedy BC, Showers CR, Anderson DE et al (2013) Tumor-associated macrophages in glioma: friend or foe? J Oncol 2013. https:\/\/doi.org\/10.1155\/2013\/486912","journal-title":"Journal of Oncology"},{"key":"1427_CR5","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3109\/08820139.2012.689591","volume":"41","author":"G Kohanbash","year":"2012","unstructured":"Kohanbash G, Okada H (2012) Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development. Immunol Investig 41:658\u2013679","journal-title":"Immunol Investig"},{"key":"1427_CR6","doi-asserted-by":"publisher","first-page":"e0122269","DOI":"10.1371\/journal.pone.0122269","volume":"10","author":"C Lapa","year":"2015","unstructured":"Lapa C, Linsenmann T, L\u00fcckerath K, Samnick S, Herrmann K, Stoffer C, Ernestus RI, Buck AK, L\u00f6hr M, Monoranu CM (2015) Tumor-associated macrophages in glioblastoma multiforme-a suitable target for somatostatin receptor-based imaging and therapy? PLoS One 10:e0122269\u2013e0122269","journal-title":"PLoS One"},{"key":"1427_CR7","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1158\/0008-5472.CAN-10-3055","volume":"71","author":"M Fujita","year":"2011","unstructured":"Fujita M, Kohanbash G, Fellows-Mayle W, Hamilton RL, Komohara Y, Decker SA, Ohlfest JR, Okada H (2011) COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells. Cancer Res 71:2664\u20132674","journal-title":"Cancer Res"},{"key":"1427_CR8","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/nm.3337","volume":"19","author":"SM Pyonteck","year":"2013","unstructured":"Pyonteck SM, Akkari L, Schuhmacher AJ, Bowman RL, Sevenich L, Quail DF, Olson OC, Quick ML, Huse JT, Teijeiro V, Setty M, Leslie CS, Oei Y, Pedraza A, Zhang J, Brennan CW, Sutton JC, Holland EC, Daniel D, Joyce JA (2013) CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med 19:1264\u20131272","journal-title":"Nat Med"},{"key":"1427_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/nan.12428","volume":"44","author":"MD Sorensen","year":"2018","unstructured":"Sorensen MD, Dahlrot RH, Boldt HB et al (2018) Tumour-associated microglia\/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype. Neuropathol Appl Neurobiol 44:185\u2013206","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1427_CR10","doi-asserted-by":"publisher","first-page":"6413","DOI":"10.1158\/0008-5472.CAN-12-4124","volume":"73","author":"G Kohanbash","year":"2013","unstructured":"Kohanbash G, McKaveney K, Sakaki M, Ueda R, Mintz AH, Amankulor N, Fujita M, Ohlfest JR, Okada H (2013) GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-\u03b1. Cancer Res 73:6413\u20136423","journal-title":"Cancer Res"},{"key":"1427_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s11060-015-1720-6","volume":"122","author":"B Raychaudhuri","year":"2015","unstructured":"Raychaudhuri B, Rayman P, Huang P, Grabowski M, Hambardzumyan D, Finke JH, Vogelbaum MA (2015) Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes. J Neuro-Oncol 122:293\u2013301","journal-title":"J Neuro-Oncol"},{"key":"1427_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevImmunol.v29.i1.10","volume":"29","author":"H Okada","year":"2009","unstructured":"Okada H, Kohanbash G, Zhu X, Kastenhuber ER, Hoji A, Ueda R, Fujita M (2009) Immunotherapeutic approaches for glioma. Crit Rev Immunol 29:1\u201342","journal-title":"Crit Rev Immunol"},{"key":"1427_CR13","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1002\/stem.2393","volume":"34","author":"B Otvos","year":"2016","unstructured":"Otvos B, Silver DJ, Mulkearns-Hubert EE, Alvarado AG, Turaga SM, Sorensen MD, Rayman P, Flavahan WA, Hale JS, Stoltz K, Sinyuk M, Wu Q, Jarrar A, Kim SH, Fox PL, Nakano I, Rich JN, Ransohoff RM, Finke J, Kristensen BW, Vogelbaum MA, Lathia JD (2016) Cancer stem cell-secreted macrophage migration inhibitory factor stimulates myeloid derived suppressor cell function and facilitates glioblastoma immune evasion. Stem Cells 34:2026\u20132039","journal-title":"Stem Cells"},{"key":"1427_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00262-013-1508-5","volume":"63","author":"C Meyer","year":"2014","unstructured":"Meyer C, Cagnon L, Costa-Nunes CM, Baumgaertner P, Montandon N, Leyvraz L, Michielin O, Romano E, Speiser DE (2014) Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab. Cancer Immunol Immunother 63:247\u2013257","journal-title":"Cancer Immunol Immunother"},{"key":"1427_CR15","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/jnen\/nly048","volume":"77","author":"D Cantero","year":"2018","unstructured":"Cantero D, Rodriguez de Lope A, Moreno de la Presa R et al (2018) Molecular study of long-term survivors of glioblastoma by gene-targeted next-generation sequencing. J Neuropathol Exp Neurol 77:710\u2013716","journal-title":"J Neuropathol Exp Neurol"},{"key":"1427_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s40478-018-0621-2","volume":"6","author":"F Erhart","year":"2018","unstructured":"Erhart F, Buchroithner J, Reitermaier R, Fischhuber K, Klingenbrunner S, Sloma I, Hibsh D, Kozol R, Efroni S, Ricken G, W\u00f6hrer A, Haberler C, Hainfellner J, Krumpl G, Felzmann T, Dohnal AM, Marosi C, Visus C (2018) Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables. Acta Neuropathol Commun 6:135","journal-title":"Acta Neuropathol Commun"},{"key":"1427_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2174\/157015912799362733","volume":"10","author":"K Suk","year":"2012","unstructured":"Suk K (2012) Proteomic analysis of glioma chemoresistance. Curr Neuropharmacol 10:72\u201379","journal-title":"Curr Neuropharmacol"},{"key":"1427_CR18","doi-asserted-by":"publisher","first-page":"8013575","DOI":"10.1155\/2017\/8013575","volume":"2017","author":"W Szopa","year":"2017","unstructured":"Szopa W, Burley TA, Kramer-Marek G, Kaspera W (2017) Diagnostic and therapeutic biomarkers in glioblastoma: current status and future perspectives. Biomed Res Int 2017:8013575","journal-title":"Biomed Res Int"},{"key":"1427_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/jmri.26171","volume":"48","author":"SC Thust","year":"2018","unstructured":"Thust SC, van den Bent MJ, Smits M (2018) Pseudoprogression of brain tumors. J Magn Reson Imaging 48:571\u2013589","journal-title":"J Magn Reson Imaging"},{"key":"1427_CR20","doi-asserted-by":"publisher","first-page":"32127","DOI":"10.1038\/srep32127","volume":"6","author":"P Shi","year":"2016","unstructured":"Shi P, Zhong J, Hong J, Huang R, Wang K, Chen Y (2016) Automated Ki-67 quantification of immunohistochemical staining image of human nasopharyngeal carcinoma xenografts. Sci Rep 6:32127","journal-title":"Sci Rep"},{"key":"1427_CR21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 57:289\u2013300","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"1427_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fphys.2018.00170","volume":"9","author":"E Ozdemir-Kaynak","year":"2018","unstructured":"Ozdemir-Kaynak E, Qutub AA, Yesil-Celiktas O (2018) Advances in glioblastoma multiforme treatment: new models for nanoparticle therapy. Front Physiol 9:170\u2013170","journal-title":"Front Physiol"},{"key":"1427_CR23","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1158\/1078-0432.CCR-16-1508","volume":"23","author":"P Rajappa","year":"2017","unstructured":"Rajappa P, Cobb WS, Vartanian E, Huang Y, Daly L, Hoffman C, Zhang J, Shen B, Yanowitch R, Garg K, Cisse B, Haddock S, Huse J, Pisapia DJ, Chan TA, Lyden DC, Bromberg JF, Greenfield JP (2017) Malignant astrocytic tumor progression potentiated by JAK-mediated recruitment of myeloid cells. Clin Cancer Res 23:3109\u20133119","journal-title":"Clin Cancer Res"},{"key":"1427_CR24","doi-asserted-by":"publisher","first-page":"20681","DOI":"10.18632\/oncotarget.25061","volume":"9","author":"T Garzon-Muvdi","year":"2018","unstructured":"Garzon-Muvdi T, Theodros D, Luksik AS et al (2018) Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma. Oncotarget 9:20681\u201320697","journal-title":"Oncotarget"},{"key":"1427_CR25","doi-asserted-by":"publisher","first-page":"17556","DOI":"10.1038\/s41598-017-17752-w","volume":"7","author":"A Gieryng","year":"2017","unstructured":"Gieryng A, Pszczolkowska D, Bocian K, Dabrowski M, Rajan WD, Kloss M, Mieczkowski J, Kaminska B (2017) Immune microenvironment of experimental rat C6 gliomas resembles human glioblastomas. Sci Rep 7:17556","journal-title":"Sci Rep"},{"key":"1427_CR26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/neuonc\/nov245","volume":"18","author":"N Butowski","year":"2016","unstructured":"Butowski N, Colman H, De Groot JF et al (2016) Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study. Neuro-Oncology 18:557\u2013564","journal-title":"Neuro-Oncology"},{"key":"1427_CR27","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3389\/fimmu.2017.00828","volume":"8","author":"G Genard","year":"2017","unstructured":"Genard G, Lucas S, Michiels C (2017) Reprogramming of tumor-associated macrophages with anticancer therapies: radiotherapy versus chemo- and immunotherapies. Front Immunol 8:828","journal-title":"Front Immunol"},{"key":"1427_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","volume":"5","author":"DI Gabrilovich","year":"2017","unstructured":"Gabrilovich DI (2017) Myeloid-derived suppressor cells. Cancer Immunol Res 5:3\u20138","journal-title":"Cancer Immunol Res"},{"key":"1427_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1479-5876-12-107","volume":"12","author":"T Oh","year":"2014","unstructured":"Oh T, Fakurnejad S, Sayegh ET, Clark AJ, Ivan ME, Sun MZ, Safaee M, Bloch O, James CD, Parsa AT (2014) Immunocompetent murine models for the study of glioblastoma immunotherapy. J Transl Med 12:107","journal-title":"J Transl Med"},{"key":"1427_CR30","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2119\/molmed.2011.00217","volume":"18","author":"SJ Coniglio","year":"2012","unstructured":"Coniglio SJ, Eugenin E, Dobrenis K, Stanley ER, West BL, Symons MH, Segall JE (2012) Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling. Mol Med 18:519\u2013527","journal-title":"Mol Med"},{"key":"1427_CR31","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1501137","volume":"7","author":"V Genoud","year":"2018","unstructured":"Genoud V, Marinari E, Nikolaev SI, Castle JC, Bukur V, Dietrich PY, Okada H, Walker PR (2018) Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models. Oncoimmunology 7:e1501137","journal-title":"Oncoimmunology"},{"key":"1427_CR32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1158\/2326-6066.CIR-15-0151","volume":"4","author":"DA Reardon","year":"2016","unstructured":"Reardon DA, Gokhale PC, Klein SR, Ligon KL, Rodig SJ, Ramkissoon SH, Jones KL, Conway AS, Liao X, Zhou J, Wen PY, van den Abbeele AD, Hodi FS, Qin L, Kohl NE, Sharpe AH, Dranoff G, Freeman GJ (2016) Glioblastoma eradication following immune checkpoint blockade in an orthotopic, immunocompetent model. Cancer Immunol Res 4:124\u2013135","journal-title":"Cancer Immunol Res"},{"key":"1427_CR33","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1172\/JCI90644","volume":"127","author":"G Kohanbash","year":"2017","unstructured":"Kohanbash G, Carrera DA, Shrivastav S, Ahn BJ, Jahan N, Mazor T, Chheda ZS, Downey KM, Watchmaker PB, Beppler C, Warta R, Amankulor NA, Herold-Mende C, Costello JF, Okada H (2017) Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas. J Clin Invest 127:1425\u20131437","journal-title":"J Clin Invest"},{"key":"1427_CR34","doi-asserted-by":"publisher","first-page":"6551","DOI":"10.1158\/1078-0432.CCR-09-1067","volume":"15","author":"R Ueda","year":"2009","unstructured":"Ueda R, Fujita M, Zhu X, Sasaki K, Kastenhuber ER, Kohanbash G, McDonald HA, Harper J, Lonning S, Okada H (2009) Systemic inhibition of transforming growth factor-beta in glioma-bearing mice improves the therapeutic efficacy of glioma-associated antigen peptide vaccines. Clin Cancer Res 15:6551\u20136559","journal-title":"Clin Cancer Res"},{"key":"1427_CR35","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11060-014-1514-2","volume":"119","author":"C Leten","year":"2014","unstructured":"Leten C, Struys T, Dresselaers T, Himmelreich U (2014) In vivo and ex vivo assessment of the blood brain barrier integrity in different glioblastoma animal models. J Neuro-Oncol 119:297\u2013306","journal-title":"J Neuro-Oncol"},{"key":"1427_CR36","doi-asserted-by":"publisher","first-page":"9801","DOI":"10.18632\/oncotarget.6877","volume":"7","author":"JT Miyauchi","year":"2016","unstructured":"Miyauchi JT, Chen D, Choi M et al (2016) Ablation of neuropilin 1 from glioma-associated microglia and macrophages slows tumor progression. Oncotarget 7:9801","journal-title":"Oncotarget"},{"key":"1427_CR37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5607\/en.2013.22.2.59","volume":"22","author":"H-K Jeong","year":"2013","unstructured":"Jeong H-K, Ji K, Min K, Joe E-H (2013) Brain inflammation and microglia: facts and misconceptions. Exp Neurobiol 22:59\u201367","journal-title":"Exp Neurobiol"},{"key":"1427_CR38","doi-asserted-by":"publisher","first-page":"6146","DOI":"10.1073\/pnas.1502609112","volume":"112","author":"M Rashidian","year":"2015","unstructured":"Rashidian M, Keliher EJ, Bilate AM, Duarte JN, Wojtkiewicz GR, Jacobsen JT, Cragnolini J, Swee LK, Victora GD, Weissleder R, Ploegh HL (2015) Noninvasive imaging of immune responses. Proc Natl Acad Sci U S A 112:6146\u20136151","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-019-01427-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-019-01427-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-019-01427-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T11:02:30Z","timestamp":1721732550000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-019-01427-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,16]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1427"],"URL":"https:\/\/doi.org\/10.1007\/s11307-019-01427-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/614511","asserted-by":"object"}]},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,16]]},"assertion":[{"value":"16 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All applicable institutional and\/or national guidelines for the care and use of animals were followed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Anderson has a research grant from Lumiphore and is on their scientific advisory board. The authors have no other conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}